EXELIXIS INC's ticker is EXEL and the CUSIP is 30161Q104. A total of 350 filers reported holding EXELIXIS INC in Q4 2020. The put-call ratio across all filers is 2.32 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $1,400,000 | +15.1% | 63,378 | -0.3% | 0.00% | +50.0% |
| Q2 2023 | $1,216,000 | +48.5% | 63,578 | +51.7% | 0.00% | 0.0% |
| Q1 2023 | $819,000 | +26.4% | 41,899 | +4.2% | 0.00% | +100.0% |
| Q4 2022 | $648,000 | +27.3% | 40,214 | +24.0% | 0.00% | 0.0% |
| Q3 2022 | $509,000 | -18.7% | 32,427 | +7.0% | 0.00% | -50.0% |
| Q2 2022 | $626,000 | -5.6% | 30,296 | +3.4% | 0.00% | +100.0% |
| Q1 2022 | $663,000 | +11.6% | 29,306 | -10.3% | 0.00% | 0.0% |
| Q4 2021 | $594,000 | -18.3% | 32,667 | -5.3% | 0.00% | -50.0% |
| Q3 2021 | $727,000 | +15.2% | 34,506 | -0.5% | 0.00% | 0.0% |
| Q2 2021 | $631,000 | -23.5% | 34,681 | -5.1% | 0.00% | -33.3% |
| Q1 2021 | $825,000 | +9.4% | 36,540 | -2.7% | 0.00% | 0.0% |
| Q4 2020 | $754,000 | -10.2% | 37,561 | +9.2% | 0.00% | -25.0% |
| Q3 2020 | $840,000 | -8.0% | 34,387 | -10.4% | 0.00% | -20.0% |
| Q2 2020 | $913,000 | +38.8% | 38,365 | +0.3% | 0.01% | +25.0% |
| Q1 2020 | $658,000 | -1.3% | 38,237 | +0.4% | 0.00% | 0.0% |
| Q4 2019 | $667,000 | -7.1% | 38,092 | -6.8% | 0.00% | 0.0% |
| Q3 2019 | $718,000 | -13.2% | 40,856 | +4.3% | 0.00% | -20.0% |
| Q2 2019 | $827,000 | -11.5% | 39,162 | -0.9% | 0.01% | -16.7% |
| Q1 2019 | $934,000 | +24.4% | 39,537 | -21.7% | 0.01% | 0.0% |
| Q4 2018 | $751,000 | +9.8% | 50,511 | -0.3% | 0.01% | +20.0% |
| Q3 2018 | $684,000 | -6.0% | 50,685 | -7.8% | 0.01% | -16.7% |
| Q2 2018 | $728,000 | -0.5% | 54,985 | +24.3% | 0.01% | 0.0% |
| Q1 2018 | $732,000 | -27.0% | 44,220 | +0.4% | 0.01% | -25.0% |
| Q4 2017 | $1,003,000 | +28.1% | 44,035 | +2.3% | 0.01% | +14.3% |
| Q3 2017 | $783,000 | -0.6% | 43,030 | +0.2% | 0.01% | 0.0% |
| Q2 2017 | $788,000 | +43.5% | 42,940 | +68.4% | 0.01% | +40.0% |
| Q1 2017 | $549,000 | +52.9% | 25,497 | +3.4% | 0.01% | +25.0% |
| Q4 2016 | $359,000 | +13.6% | 24,662 | 0.0% | 0.00% | 0.0% |
| Q3 2016 | $316,000 | +10.1% | 24,662 | -32.7% | 0.00% | 0.0% |
| Q2 2016 | $287,000 | +80.5% | 36,662 | -7.6% | 0.00% | +300.0% |
| Q1 2016 | $159,000 | -29.0% | 39,662 | -0.4% | 0.00% | -66.7% |
| Q4 2015 | $224,000 | -5.1% | 39,822 | -4.8% | 0.00% | 0.0% |
| Q3 2015 | $236,000 | +56.3% | 41,822 | +3.8% | 0.00% | +50.0% |
| Q2 2015 | $151,000 | +41.1% | 40,287 | -3.5% | 0.00% | 0.0% |
| Q1 2015 | $107,000 | +101.9% | 41,762 | +13.6% | 0.00% | +100.0% |
| Q4 2014 | $53,000 | -15.9% | 36,762 | -11.0% | 0.00% | 0.0% |
| Q3 2014 | $63,000 | -55.3% | 41,315 | -0.5% | 0.00% | -50.0% |
| Q2 2014 | $141,000 | -3.4% | 41,515 | +0.5% | 0.00% | -33.3% |
| Q1 2014 | $146,000 | -41.1% | 41,315 | +2.0% | 0.00% | -40.0% |
| Q4 2013 | $248,000 | +29.2% | 40,515 | +22.9% | 0.01% | 0.0% |
| Q3 2013 | $192,000 | +32.4% | 32,962 | +3.1% | 0.01% | +25.0% |
| Q2 2013 | $145,000 | – | 31,962 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Meditor Group Ltd | 15,001,073 | $265,294,000 | 64.62% |
| Sargent Investment Group, LLC | 465,620 | $8,234,000 | 3.70% |
| Orbimed Advisors | 3,912,900 | $69,200,000 | 1.31% |
| Bellevue Group AG | 3,858,700 | $68,241,000 | 1.27% |
| TEALWOOD ASSET MANAGEMENT INC | 137,129 | $2,425,000 | 1.04% |
| CAPITAL MANAGEMENT CORP /VA | 200,995 | $3,555,000 | 0.97% |
| Penn Capital Management Company, LLC | 517,988 | $9,161,000 | 0.96% |
| Chicago Capital, LLC | 801,560 | $14,176,000 | 0.95% |
| Portolan Capital Management | 454,444 | $8,037,000 | 0.91% |
| INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 103,534 | $1,830,000 | 0.85% |